Medicaid Reform Should Be PhRMA Priority, HHS Secretary Thompson Says
Executive Summary
Passage of a Medicaid reform bill would do more to improve the pharmaceutical industry's image than a Medicare prescription drug benefit, HHS Secretary Thompson maintained during the PhRMA annual meeting in Naples, Fla. March 29
You may also be interested in...
SARS Infects Rx Industry: Vaccines Tested Against Virus; Antivirals Donated
GlaxoSmithKline, Wyeth, Merck and Aventis-Pasteur have been asked by HHS to test their vaccines against coronavirus in an effort to help find a prevention for severe acute respiratory syndrome
SARS Infects Rx Industry: Vaccines Tested Against Virus; Antivirals Donated
GlaxoSmithKline, Wyeth, Merck and Aventis-Pasteur have been asked by HHS to test their vaccines against coronavirus in an effort to help find a prevention for severe acute respiratory syndrome
Medicare Rx Funding Will Exceed $400 Bil., Breaux Predicts; War No Obstacle
Senate Medicare Rx legislation is likely to exceed the $400 bil. in funding set aside for the program by President Bush, Sen. John Breaux (D-La.) told the Pharmaceutical Research & Manufacturers of America annual meeting March 28 in Naples, Fla